rs34486484

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001151.4(SLC25A4):​c.681G>A​(p.Val227Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00197 in 1,614,218 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0090 ( 20 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 24 hom. )

Consequence

SLC25A4
NM_001151.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.12

Publications

4 publications found
Variant links:
Genes affected
SLC25A4 (HGNC:10990): (solute carrier family 25 member 4) This gene is a member of the mitochondrial carrier subfamily of solute carrier protein genes. The product of this gene functions as a gated pore that translocates ADP from the cytoplasm into the mitochondrial matrix and ATP from the mitochondrial matrix into the cytoplasm. The protein forms a homodimer embedded in the inner mitochondria membrane. Mutations in this gene have been shown to result in autosomal dominant progressive external opthalmoplegia and familial hypertrophic cardiomyopathy. [provided by RefSeq, Jun 2013]
SLC25A4 Gene-Disease associations (from GenCC):
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • mitochondrial DNA depletion syndrome 12B (cardiomyopathic type), autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae)
  • Fontaine progeroid syndrome
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • mitochondrial DNA depletion syndrome 12A (cardiomyopathic type), autosomal dominant
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant progressive external ophthalmoplegia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Sengers syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Leigh syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 4-185145841-G-A is Benign according to our data. Variant chr4-185145841-G-A is described in ClinVar as Benign. ClinVar VariationId is 139152.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.12 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00897 (1366/152346) while in subpopulation AFR AF = 0.0305 (1267/41582). AF 95% confidence interval is 0.0291. There are 20 homozygotes in GnomAd4. There are 610 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 20 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC25A4NM_001151.4 linkc.681G>A p.Val227Val synonymous_variant Exon 3 of 4 ENST00000281456.11 NP_001142.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC25A4ENST00000281456.11 linkc.681G>A p.Val227Val synonymous_variant Exon 3 of 4 1 NM_001151.4 ENSP00000281456.5
SLC25A4ENST00000491736.1 linkn.*458G>A non_coding_transcript_exon_variant Exon 3 of 4 5 ENSP00000476711.1
SLC25A4ENST00000491736.1 linkn.*458G>A 3_prime_UTR_variant Exon 3 of 4 5 ENSP00000476711.1

Frequencies

GnomAD3 genomes
AF:
0.00896
AC:
1364
AN:
152228
Hom.:
20
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0305
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00308
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.0110
GnomAD2 exomes
AF:
0.00270
AC:
680
AN:
251388
AF XY:
0.00195
show subpopulations
Gnomad AFR exome
AF:
0.0308
Gnomad AMR exome
AF:
0.00185
Gnomad ASJ exome
AF:
0.00576
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000387
Gnomad OTH exome
AF:
0.00195
GnomAD4 exome
AF:
0.00124
AC:
1813
AN:
1461872
Hom.:
24
Cov.:
32
AF XY:
0.00111
AC XY:
810
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.0328
AC:
1098
AN:
33480
American (AMR)
AF:
0.00197
AC:
88
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00566
AC:
148
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000927
AC:
8
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00433
AC:
25
AN:
5768
European-Non Finnish (NFE)
AF:
0.000244
AC:
271
AN:
1112002
Other (OTH)
AF:
0.00288
AC:
174
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
97
193
290
386
483
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00897
AC:
1366
AN:
152346
Hom.:
20
Cov.:
32
AF XY:
0.00819
AC XY:
610
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.0305
AC:
1267
AN:
41582
American (AMR)
AF:
0.00307
AC:
47
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00403
AC:
14
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
68028
Other (OTH)
AF:
0.0109
AC:
23
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
68
135
203
270
338
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00442
Hom.:
6
Bravo
AF:
0.0102
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.000872
EpiControl
AF:
0.000237

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 08, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Nov 19, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
10
DANN
Benign
0.51
PhyloP100
2.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34486484; hg19: chr4-186066995; API